- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-412/15: Judgment of the Court (Third Chamber) of 5 October 2016 (request for a preliminary ruling from the Hessisches Finanzgericht — Germany) — TMD Gesellschaft für transfusionsmedizinische Dienste mbH v Finanzamt Kassel II — Hofgeismar (Reference for a preliminary ruling — Taxation — Value added tax — Directive 2006/112/EC — Exemptions for certain activities in the public interest — Article 132(1)(d) — Supplies of human organs, blood and milk — Scope — Plasma of human blood transformed and used for industrial purposes)
ECLI:EU:UNKNOWN:62015CA0412
62015CA0412
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
28.11.2016
Official Journal of the European Union
C 441/3
(Case C-412/15) (<span class="super note-tag">1</span>)
((Reference for a preliminary ruling - Taxation - Value added tax - Directive 2006/112/EC - Exemptions for certain activities in the public interest - Article 132(1)(d) - Supplies of human organs, blood and milk - Scope - Plasma of human blood transformed and used for industrial purposes))
(2016/C 441/04)
Language of the case: German
Referring court
Parties to the main proceedings
Applicant: TMD Gesellschaft für transfusionsmedizinische Dienste mbH
Defendant: Finanzamt Kassel II — Hofgeismar
Operative part of the judgment
Article 132(1)(d) of Council Directive 2006/112/EC of 28 November 2006 on the common system of value added tax must be interpreted to the effect that supplies of human blood which Member States are required to exempt by virtue of that provision do not include supplies of plasma obtained from human blood where that plasma is intended to be used, not for direct therapeutic purposes, but exclusively for the manufacture of medicinal products.
(<span class="note">1</span>) OJ C 398, 30.11.2015.